Induction of autologous tumor-specific cytotoxic T cells in patients with liver cancer. Characterizations and clinical utilization

This publication has 13 references indexed in Scilit:

• Transcatheter arterial injection of autologous lymphokine-activated killer (LAK) cells into patients with liver cancers
  Journal of Clinical Immunology, 1990
• Tumor-infiltrating lymphocytes from human colon carcinomas
  Gastroenterology, 1990
• Immunotherapy of hepatocellular carcinoma with autologous lymphokine-activated killer cells and/or recombinant interleukin-2
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1988
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Clinical trial of trans-arterial administration of LAK and IL-2 to patient with hepatocellural carcinoma - Case reports.
  Kanzo, 1987
• Stimulation of peripheral blood lymphocytes with autologous tumor and serum-derived fractions from patients with laryngeal carcinomas
  European Archives of Oto-Rhino-Laryngology, 1986
• Treatment for unresectable hepatoma via selective hepatic arterial infusion of lymphokine-activated killer cells generated from autologous spleen cells
  Cancer, 1986
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985
• Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse
  Cellular Immunology, 1978
• Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.
  The Journal of Experimental Medicine, 1977